Skip to ContentSkip to Navigation
About us Latest news News News articles

Cerebral oxygenation in newborn infants at risk

07 November 2012

PhD ceremony: Ms. E.A. Verhagen, 16.15 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Cerebral oxygenation in newborn infants at risk

Promotor(s): prof. A.F. Bos

Faculty: Medical Sciences

One of the main aims of present-day neonatology is the prevention of major neurodevelopmental problems due to brain damage. Perinatal and neonatal risk factors causing disturbed cerebral oxygenation may harm the integrity and development of the young preterm and ill term-born brain. Cerebral oxygenation can be assessed by means of near-infrared spectroscopy (NIRS). NIRS measures regional cerebral tissue oxygen saturation (rcSO2) and allows calculation of fractional tissue oxygen extraction (FTOE) by combining rcSO2 and arterial oxygen saturation (SpO2) values: FTOE=(SpO2-rcSO2)/SpO2.

The primary aim of this thesis was to determine the clinical value of monitoring cerebral oxygenation by means of NIRS. Our second aim was to determine the course of rcSO2 and FTOE during the first weeks after birth in newborn infants at risk of disturbed cerebral oxygenation. In a heterogeneous group of preterm infants we demonstrated a negative association between both low and high neonatal rcSO2 and FTOE, and neurodevelopmental outcome at 2-3 years of age. Overall, and in each single study, we found decreasing rcSO2 and increasing FTOE during the first two weeks after birth. We explained this by an increased cerebral metabolic rate resulting in lower cerebral oxygen saturation and higher extraction.

Our studies add to the current understanding that NIRS is potentially a useful clinical tool that reflects cerebral perfusion, helps to identify the pathophysiology of several perinatal and neonatal morbidities, and may contribute to the prediction of, and possibly help prevent adverse outcomes of preterm-born children. In this way, NIRS has added value to neonatology.

Last modified:13 March 2020 12.59 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.